BR0008427A - Hidrolisado de proteìna do leite destinado a um distúrbio dentário ou ósseo - Google Patents
Hidrolisado de proteìna do leite destinado a um distúrbio dentário ou ósseoInfo
- Publication number
- BR0008427A BR0008427A BR0008427-1A BR0008427A BR0008427A BR 0008427 A BR0008427 A BR 0008427A BR 0008427 A BR0008427 A BR 0008427A BR 0008427 A BR0008427 A BR 0008427A
- Authority
- BR
- Brazil
- Prior art keywords
- milk protein
- protein hydrolyzate
- dental
- bone
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/08—Dairy proteins
- A23J3/10—Casein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/325—Working-up of proteins for foodstuffs by hydrolysis using chemical agents of casein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Patente de Invenção: "HIDROLISADO DE PROTEìNA DO LEITE DESTINADO A UM DISTúRBIO DENTáRIO OU óSSEO". Composição para a prevenção ou tratamento de um distúrbio ósseo ou dentário a qual compreende um hidrolisado de proteína do leite, uso do hidrolisado de proteína de leite na fabricação de uma composição para o tratamento ou prevenção de um distúrbio ósseo ou dentário e um método de tratamento o qual compreende a administração de uma quantidade efetiva de um hidrolisado de proteína do leite. Nas concretizações preferidas, o hidrolisado de proteína do leite é um hidrolisado de caseína, em particular um caseinoglicomacropeptídeo (CGMP), um mimético, homólogo ou fragmento do mesmo em uma forma biodisponível o qual mantém a capacidade do CGMP de inibir a reabsorção óssea ou perda óssea; ou favorecer a absorção, retenção de cálcio ou calcificação; ou uma combinação dos mesmos.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99200544A EP1062876A1 (en) | 1999-02-25 | 1999-02-25 | Caseinoglycomacropeptides as calcification agent |
PCT/EP2000/001562 WO2000049885A1 (en) | 1999-02-25 | 2000-02-25 | Milk protein hydrolysate for addressing a bone or dental disorder |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0008427A true BR0008427A (pt) | 2002-01-29 |
Family
ID=8239923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0008427-1A BR0008427A (pt) | 1999-02-25 | 2000-02-25 | Hidrolisado de proteìna do leite destinado a um distúrbio dentário ou ósseo |
Country Status (9)
Country | Link |
---|---|
EP (2) | EP1062876A1 (pt) |
JP (1) | JP2002537313A (pt) |
CN (1) | CN1352528A (pt) |
AU (1) | AU3282400A (pt) |
BR (1) | BR0008427A (pt) |
CA (1) | CA2360490A1 (pt) |
MX (1) | MXPA01006822A (pt) |
WO (1) | WO2000049885A1 (pt) |
ZA (1) | ZA200107831B (pt) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001302539A (ja) * | 2000-04-26 | 2001-10-31 | Meiji Seika Kaisha Ltd | 骨強化剤、骨強化用食品及び骨強化用飼料組成物 |
IL155242A0 (en) * | 2000-10-10 | 2003-11-23 | Bopa Ireland Ltd | A dairy product |
WO2002100181A2 (en) * | 2001-06-08 | 2002-12-19 | Societe Des Produits Nestle S.A. | Sugar-based composition containing caseinoglycomacropeptide |
FR2836014B1 (fr) * | 2002-02-15 | 2004-07-23 | Gervais Danone Sa | Nouveau procede de fabrication de produits laitiers fermentes mettant en oeuvre des enzymes d'origine bacterienne |
JP4268785B2 (ja) * | 2002-04-11 | 2009-05-27 | 株式会社ロッテ | カルシウム吸収促進及びリン酸カルシウム結晶成長促進剤 |
JP2004315477A (ja) * | 2003-04-18 | 2004-11-11 | Tokyoto Koreisha Kenkyu Fukushi Shinko Zaidan | 骨吸収抑制剤 |
GB0321996D0 (en) * | 2003-09-19 | 2003-10-22 | Novartis Nutrition Ag | Organic compounds |
JP2008503563A (ja) | 2004-06-23 | 2008-02-07 | ロレアル | 敏感及び/又は乾燥肌の予防及び/又は処置に有用な方法及び組成物 |
DE102007022694A1 (de) * | 2007-05-11 | 2008-11-13 | Humana Milchunion Eg | Milchfett-Milchprotein-Zusammensetzung zur Verbesserung der Calcium-Aufnahme |
WO2008147228A1 (en) * | 2007-05-31 | 2008-12-04 | Fonterra Corporate Research And Development Limited | Treatment or prevention of bone conditions |
FR2920305B1 (fr) | 2007-09-04 | 2010-07-30 | Oreal | Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles. |
FR2920304B1 (fr) | 2007-09-04 | 2010-06-25 | Oreal | Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse. |
FR2942719B1 (fr) | 2009-03-04 | 2011-08-19 | Oreal | Utilisation de microorganismes probiotiques pour limiter les irritations cutanees |
CN102469803B (zh) * | 2009-06-30 | 2014-08-20 | 科·汉森有限公司 | 制造发酵奶制品的方法 |
EP2456448A1 (en) * | 2009-07-20 | 2012-05-30 | Nestec S.A. | Methods of attenuating the loss of functional status |
US9180168B2 (en) * | 2012-01-31 | 2015-11-10 | Wisconsin Alumni Research Foundation | Use of glycomacropeptide to improve women's health |
WO2016108064A1 (en) * | 2014-12-31 | 2016-07-07 | Compagnie Gervais Danone | Foaming dairy compositions |
WO2018134066A1 (en) * | 2017-01-19 | 2018-07-26 | Chr. Hansen A/S | Casein glycomacropeptide (cgmp) oligomers |
DE102017202134A1 (de) | 2017-02-10 | 2018-08-16 | Intercell Pharma Gmbh | Präparat zur Behandlung der nachteiligen Begleiterscheinungen von Magensäureblockern |
BR112020026032A2 (pt) * | 2018-06-18 | 2021-03-23 | Probi Ab | composições probióticas e usos das mesmas |
CN116904378B (zh) * | 2023-09-14 | 2023-12-29 | 山东中科嘉亿生物工程有限公司 | 促进骨成长的约氏乳杆菌jylo-010及菌剂、应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH671879A5 (pt) * | 1987-02-26 | 1989-10-13 | Nestle Sa | |
JP2622686B2 (ja) * | 1987-05-15 | 1997-06-18 | 雪印乳業株式会社 | k−カゼイングリコマクロペプチドの製造法 |
CH681543A5 (pt) * | 1990-04-27 | 1993-04-15 | Nestle Sa | |
JP2786001B2 (ja) * | 1990-07-09 | 1998-08-13 | 森永乳業株式会社 | チロシナーゼ活性阻害剤 |
JP3160862B2 (ja) * | 1990-11-15 | 2001-04-25 | 雪印乳業株式会社 | 骨強化食品、飼料及び医薬 |
US5670201A (en) * | 1991-06-21 | 1997-09-23 | Snow Brand Milk Co., Ltd. | Low allergenic nutrient composition and method of using same |
JP3542190B2 (ja) * | 1995-03-10 | 2004-07-14 | 明治乳業株式会社 | カルシウム−カゼインホスホペプチド調製物の製造方法、骨塩減少抑制食品及び骨塩減少抑制剤 |
JPH08275735A (ja) * | 1995-04-07 | 1996-10-22 | Nippon Haigou Shiryo Kk | 養魚飼料及び魚類の飼育方法 |
JP3575724B2 (ja) * | 1996-10-25 | 2004-10-13 | 雪印乳業株式会社 | カルシウム吸収促進剤 |
BR9809650A (pt) * | 1997-05-19 | 2000-07-11 | Colgate Palmolive Co | Composição oral para remineralização dos dentes, e, processo para remineralizar porções desmineralizadas das estruturas de dentes |
US5853704A (en) * | 1997-09-22 | 1998-12-29 | Colgate-Palmolive Company | Fluoride dentifrices of enhanced efficacy |
EP1102543B1 (fr) * | 1998-08-07 | 2006-08-30 | Société des Produits Nestlé S.A. | Produit laitier anti-cariogene et son utilisation |
-
1999
- 1999-02-25 EP EP99200544A patent/EP1062876A1/en not_active Withdrawn
-
2000
- 2000-02-25 BR BR0008427-1A patent/BR0008427A/pt not_active Application Discontinuation
- 2000-02-25 WO PCT/EP2000/001562 patent/WO2000049885A1/en not_active Application Discontinuation
- 2000-02-25 AU AU32824/00A patent/AU3282400A/en not_active Abandoned
- 2000-02-25 EP EP00910712A patent/EP1154701A1/en not_active Withdrawn
- 2000-02-25 CN CN00803922A patent/CN1352528A/zh active Pending
- 2000-02-25 JP JP2000600503A patent/JP2002537313A/ja not_active Withdrawn
- 2000-02-25 CA CA002360490A patent/CA2360490A1/en not_active Abandoned
-
2001
- 2001-07-03 MX MXPA01006822 patent/MXPA01006822A/es unknown
- 2001-09-21 ZA ZA200107831A patent/ZA200107831B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU3282400A (en) | 2000-09-14 |
ZA200107831B (en) | 2002-12-23 |
MXPA01006822A (es) | 2001-10-01 |
CA2360490A1 (en) | 2000-08-31 |
EP1062876A1 (en) | 2000-12-27 |
JP2002537313A (ja) | 2002-11-05 |
CN1352528A (zh) | 2002-06-05 |
EP1154701A1 (en) | 2001-11-21 |
WO2000049885A1 (en) | 2000-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0008427A (pt) | Hidrolisado de proteìna do leite destinado a um distúrbio dentário ou ósseo | |
BR0308901A (pt) | ácidos bisfosfÈnicos para tratamento e prevenção de osteoporose | |
BR0110659A (pt) | Composição farmacêutica, kit, uso de um fator viia em combinação com um fator, xiii, e, métodos para intensificação da formação de coágulo de fibrina em um indivìduo e para tratar de episódios de hemorragia em um indivìduo | |
BR0214838A (pt) | Composição para promoção de crescimento ósseo e manutenção da saúde óssea | |
BR9808786A (pt) | Composto peptìdio cìclico ou um seu sal ou pró-medicamento farmaceuticamente aceitáveis, composição farmacêutica, e, processos para tratar doenças associadas com a regulagem do cálcio em um paciente e para tratar a osteopenia ou a osteoporose em um mamìfero hospedeiro | |
BR9900775A (pt) | Tratamento de desordens do esqueleto. | |
FR2705235B1 (fr) | Utilisation de particules d'un sel de calcium biocompatible et biorésorbable comme ingrédient actif dans la préparation d'un médicament destiné au traitement local des maladies déminéralisantes de l'os. | |
BR0111913A (pt) | Análogos de gabapentina para distúrbios do sono | |
FR2699077B1 (fr) | Application d'anticonvulsivants dans le traitement de lésions neurologiques liées à des traumatismes. | |
BR9807673A (pt) | Processos para tratar asma alérgica e dermatite em um humano e composição farmacêutica. | |
PT867178E (pt) | Utilizacao de agonistas nao alostericos de gaba para o tratamento de desordens do sono | |
FI970703A0 (fi) | Neutraalin makuisen, hydrolysoidun kollageenin käyttö ja sitä sisältävä aine | |
BR9811780A (pt) | Método de aumento de volume ósseo usando agonistas seletivos fp não ocorrendo naturalmente | |
CA2275595A1 (en) | Prevention and treatment of skeletal disorder with ep2 receptor subtype selective prostaglandin e2 agonists | |
BR9914735A (pt) | Processo para tratamento de sépsia | |
BR9506581A (pt) | Composto composição farmacêutica uso do composto processo para a profilaxia ou tratamento de uma condição clínica em um manífero por exemplo um humano e para a preparação de um composto e composto intermediário | |
BR0010669A (pt) | Método para o tratamento de fibrose usando um antagonista da subunidade alfa-4 da integrina | |
BR9812660A (pt) | Composições e métodos para tratar distúrbios respiratórios | |
EP1632248B8 (en) | Anti-interleukin-9 antibody or anti-interleukin-9 receptor antibody for treating bronchial hyper-responsiveness | |
BR9814214A (pt) | Composição com ácido azeláico | |
BR9911917A (pt) | Composições compreendendo análogos de gaba e cafeìna | |
ZA966578B (en) | Pharmaceutical composition. | |
ATE445409T1 (de) | Zusammensetzungen mit matrixproteinen zur regeneration von dentin | |
BR0116983A (pt) | Composição, e, método de tratamento dos dentes com flúor em um ambiente oral contendo material de carbonato de cálcio | |
BR9808233A (pt) | Preparação farmacêutica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired | ||
B15K | Others concerning applications: alteration of classification |
Ipc: A23J 3/10 (2006.01), A23J 3/32 (2006.01), A23L 33/ |